Literature DB >> 26973172

Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery.

Muhammad Nawaz1,2, Farah Fatima1,2, Irina Nazarenko3, Karin Ekström4,5, Iram Murtaza6, Mariam Anees6, Aneesa Sultan6, Luciano Neder1, Giovanni Camussi7, Hadi Valadi2, Jeremy A Squire1, Thomas Kislinger8.   

Abstract

In recent years there has been tremendous interest in both the basic biology and applications of extracellular vesicles (EVs) in translational cancer research. This includes a better understanding of their biogenesis and mechanisms of selective cargo packaging, their precise roles in horizontal communication, and their application as non-invasive biomarkers. The rapid advances in next-generation omics technologies are the driving forces for these discoveries. In this review, the authors focus on recent results of EV research in ovarian cancer. A deeper understanding of ovarian cancer-derived EVs, the types of cargo molecules and their biological roles in cancer growth, metastases and drug resistance, could have significant impact on the discovery of novel biomarkers and innovative therapeutics. Insights into the role of EVs in immune regulation could lead to novel approaches built on EV-based immunotherapy.

Entities:  

Keywords:  Extracellular vesicles; biomarkers; exosomes; glycoproteins; immunotherapy; matrix metalloproteinase; microRNAs; ovarian cancer

Mesh:

Substances:

Year:  2016        PMID: 26973172     DOI: 10.1586/14789450.2016.1165613

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  32 in total

Review 1.  Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases.

Authors:  J Meldolesi
Journal:  Clin Exp Immunol       Date:  2019-03-11       Impact factor: 4.330

2.  Nexus between extracellular vesicles, immunomodulation and tissue remodeling: for good or for bad?

Authors:  Farah Fatima; Muhammad Nawaz
Journal:  Ann Transl Med       Date:  2017-03

Review 3.  Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance.

Authors:  Muhammad Nawaz
Journal:  Stem Cell Investig       Date:  2017-10-24

Review 4.  Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer.

Authors:  Zehong Yang; Hongyan Xu; Xiaojun Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-03-20       Impact factor: 16.806

Review 5.  Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.

Authors:  Shruti Mishra; Sumit S Verma; Vipin Rai; Nikee Awasthee; Srinivas Chava; Kam Man Hui; Alan Prem Kumar; Kishore B Challagundla; Gautam Sethi; Subash C Gupta
Journal:  Cell Mol Life Sci       Date:  2019-03-16       Impact factor: 9.261

Review 6.  New Technologies for Analysis of Extracellular Vesicles.

Authors:  Huilin Shao; Hyungsoon Im; Cesar M Castro; Xandra Breakefield; Ralph Weissleder; Hakho Lee
Journal:  Chem Rev       Date:  2018-01-31       Impact factor: 60.622

Review 7.  Small extracellular vesicles in cancer.

Authors:  Komal Abhange; Amy Makler; Yi Wen; Natasha Ramnauth; Wenjun Mao; Waseem Asghar; Yuan Wan
Journal:  Bioact Mater       Date:  2021-04-07

Review 8.  Extracellular Vesicles and Their Current Role in Cancer Immunotherapy.

Authors:  Carla Giacobino; Marta Canta; Cristina Fornaguera; Salvador Borrós; Valentina Cauda
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

9.  Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.

Authors:  David W Greening; Hong Ji; Maoshan Chen; Bruce W S Robinson; Ian M Dick; Jenette Creaney; Richard J Simpson
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

10.  The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis.

Authors:  Majid Alhomrani; Jeanne Correia; Marcus Zavou; Bryan Leaw; Nathan Kuk; Rong Xu; Mohamed I Saad; Alexander Hodge; David W Greening; Rebecca Lim; William Sievert
Journal:  Front Pharmacol       Date:  2017-10-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.